Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma

被引:13
|
作者
Mundada, Pravin [1 ]
Varoquaux, Arthur Damien [2 ]
Lenoir, Vincent [1 ]
de Vito, Claudio [3 ]
Dulguerov, Nicolas [4 ]
Ailianou, Angeliki [1 ,6 ]
Caparrotti, Francesca [5 ]
Becker, Minerva [1 ]
机构
[1] Univ Geneva, Geneva Univ Hosp, Div Radiol, Dept Imaging & Med Informat, Geneva, Switzerland
[2] Aix Marseille Med Univ, Ctr Magnet Resonance Biol & Med, Marseille, France
[3] Univ Geneva, Geneva Univ Hosp, Dept Lab Med Genet & Pathol, Div Clin Pathol, Geneva, Switzerland
[4] Univ Geneva, Geneva Univ Hosp, Dept Clin Neurosci, Clin Otorhinolaryngol Head & Neck Surg, Geneva, Switzerland
[5] Geneva Univ Hosp, Dept Oncol, Div Radiat Oncol, Geneva, Switzerland
[6] Hosp Neuchatel, Dept Imaging, Div Radiol, Neuchatel, Switzerland
关键词
Head and neck squamous cell carcinoma; Post-treatment loco-regional failure; Lymph node recurrence; Diffusion weighted imaging; MRI; POSITRON-EMISSION-TOMOGRAPHY; FDG-PET; RADIATION TREATMENT; FOLLOW-UP; CHEMORADIOTHERAPY; CANCER; TUMORS; RADIOTHERAPY; METAANALYSIS; METASTASIS;
D O I
10.1016/j.ejrad.2018.02.026
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To determine the diagnostic performance of morphologic MRI with diffusion weighted imaging (DWIMRI) for the detection of post-treatment lymph node (LN) recurrence of head and neck squamous cell carcinoma (HNSCC). Methods: This retrospective study is based on 33 HNSCC patients who underwent DWIMRI with apparent diffusion coefficient (ADC) measurements for suspected post-treatment loco-regional failure. Two radiologists, blinded to clinical/histopathological data, analyzed MR images according to established morphologic criteria and measured ADC values by drawing regions of interest on each normal/abnormal looking lymph node (LN). Histopathological findings in 40 neck dissections, 133 LN-levels and 755 LNs served as gold standard. Results: Malignant LNs had lower ADCmean values than benign LNs (1.15 +/- 0.35x10(-3) mm(2)/s versus 1.28 +/- 0.28x10(-3) mm(2)/s, p = .028). The optimal ADCmean threshold to differentiate malignant from benign LNs was 1.1695x10(-3) mm(2)/s. Sensitivity, specificity, positive (PPV) and negative (NPV) predictive values (95% CI in parentheses) of DWIMRI with morphologic criteria and ADCmean<1.1695x10(-3)mm(2)/s were: (a) 100%(86.2; 100), 44.4%(15.3; 77.3), 86.1%(69.7; 94.7), and 100%(39.5; 100) per neck dissection; (b) 83.6%(69.7; 92.2), 91.6%(83.0; 96.2), 85.4%(71.6; 93.4), and 90.5%(81.7; 95.5) per LN-level; (c) 53.1%(43.5; 62.4), 95.5%(93.5; 96.9), 67.4%(56.6; 76.7), and 92.0%(89.6; 93.9) per LN, respectively. Conclusion: The high NPV of DWIMRI irrespective of analysis type (per neck dissection/per neck level/per lymph node) make it a useful follow-up tool after treatment.
引用
收藏
页码:162 / 169
页数:8
相关论文
共 50 条
  • [31] Treatment of Oligometastatic Disease in Squamous Cell Carcinoma of the Head and Neck
    Vincent, Aurora G.
    Wang, Weitao
    Shokri, Tom
    Ducic, Yadranko
    LARYNGOSCOPE, 2021, 131 (05): : E1476 - E1480
  • [32] Imaging in head and neck squamous cell carcinoma: the potential role of PET/MRI
    Becker, Minerva
    Zaidi, Habib
    BRITISH JOURNAL OF RADIOLOGY, 2014, 87 (1036):
  • [33] Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 Tesla
    Fruehwald-Pallamar, Julia
    Czerny, Christian
    Mayerhoefer, Marius E.
    Halpern, Benjamin S.
    Eder-Czembirek, Christina
    Brunner, Markus
    Schuetz, Matthias
    Weber, Michael
    Fruehwald, Laura
    Herneth, Andreas M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (06) : 1009 - 1019
  • [34] DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck
    King, Ann D.
    Chow, Steven Kwok Keung
    Yu, Kwok-Hung
    Mo, Frankie Kwok Fai
    Yeung, David K. W.
    Yuan, Jing
    Law, Benjamin King Hong
    Bhatia, Kunwar S.
    Vlantis, Alexander C.
    Ahuja, Anil T.
    PLOS ONE, 2015, 10 (12):
  • [35] Diffusion-weighted Magnetic Resonance Imaging for Predicting Response to Chemoradiation Therapy for Head and Neck Squamous Cell Carcinoma: A Systematic Review
    Chung, Sae Rom
    Choi, Young Jun
    Suh, Chong Hyun
    Lee, Jeong Hyun
    Baek, Jung Hwan
    KOREAN JOURNAL OF RADIOLOGY, 2019, 20 (04) : 649 - 661
  • [36] Biomechanical imaging biomarker during chemoradiotherapy predicts treatment response in head and neck squamous cell carcinoma
    Fujimoto, Koya
    Shiinoki, Takehiro
    Kawazoe, Yusuke
    Yuasa, Yuki
    Mukaidani, Wataru
    Manabe, Yuki
    Kajima, Miki
    Tanaka, Hidekazu
    PHYSICS IN MEDICINE AND BIOLOGY, 2024, 69 (05):
  • [37] Meta-analysis of diffusion-weighted imaging for predicting locoregional failure of chemoradiotherapy in patients with head and neck squamous cell carcinoma
    Zhou, Qiming
    Zeng, Fangfang
    Ding, Yao
    Fuller, Clifton D.
    Wang, Jihong
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 8 (01) : 197 - 203
  • [38] Diffusion-Weighted Imaging (DWI) derived from PET/MRI for lymph node assessment in patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
    Freihat, Omar
    Pinter, Tamas
    Kedves, Andras
    Sipos, David
    Cselik, Zsolt
    Repa, Imre
    Kovacs, Arpad
    CANCER IMAGING, 2020, 20 (01)
  • [39] Diffusion-Weighted Imaging (DWI) derived from PET/MRI for lymph node assessment in patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
    Omar Freihat
    Tamas Pinter
    András Kedves
    Dávid Sipos
    Zsolt Cselik
    Imre Repa
    Árpád Kovács
    Cancer Imaging, 20
  • [40] Diffusion-weighted magnetic resonance imaging (DWMRI) of head and neck squamous cell carcinoma: could it be an imaging biomarker for prediction of response to chemoradiation therapy
    Khattab, Hanan Mohamed
    Montasser, Moataz Mohamed
    Eid, Mohamed
    Kandil, Alaa
    Desouky, Salah El-Din
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2020, 51 (01):